Stockwinners Market Radar for May 28, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:42 EDT On The Fly: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Qualcomm (QCOM) is expecting to meet this week with China's antitrust regulators in a final push to secure clearance for its proposed $44B acquisition of NXP Semiconductors (NXPI), according to Reuters, citing three sources. 2. Myriad Genetics (MYGN) announced that it has signed a definitive agreement to acquire Counsyl for $375M through a combination of cash and Myriad common stock. On completion of the transaction, which is expected to close in Myriad's fiscal first quarter 2019, Counsyl will become a wholly owned subsidiary of Myriad. 3. Micron's (MU) stock valuation has remained unchanged even as its stock price has more than doubled over the past 12 months on better financial results, Tiernan Ray wrote in this week's edition of Barron's. But as Micron makes more parts that are distinctive it can escape persistent worries about supply and achieve a higher stock multiple, he contended. 4. Disney's (DIS) Han Solo origin tale "Solo: A Star Wars Story" battled to hit $103M domestically and only got $65M overseas. The movie trailed the launch of fellow stand-alone pic "Rogue One: A Star Wars Story," which debuted to $155M domestically in 2016. "Solo: A Star Wars Story" earned an A- CinemaScore and sports an 70% Rotten Tomatoes score. 5. Kraft Heinz (KHC), Merck (MRK), Target (TGT), Omnicom Group (OMC), Carnival (CCL), Johnson & Johnson (JNJ), 3M (MMM), Eli Lille (LLY), Valero (VLO), Emerson Electric (EMR), Walgreens Boots Alliance (WBA), Altice USA (ATUS), and Dollar Tree (DLTR) saw positive mentions in Barron's.

18:12 EDT Myriad Genetics signs definitive agreement to acquire Counsyl - Myriad Genetics announced that it has signed a definitive agreement to acquire Counsyl, a pioneer in expanded carrier screening and non-invasive prenatal screening for $375M through a combination of cash and Myriad common stock. On completion of the transaction, which is expected to close in Myriad's fiscal first quarter 2019, Counsyl will become a wholly owned subsidiary of Myriad. Myriad estimates that approximately 900,000 carrier screening tests and approximately 1.3M non-invasive prenatal screening tests will be performed in the U.S. during its fiscal year 2018. The company believes these markets will grow at a double-digit rate with approximately 3.5M total reproductive genetic tests performed in the U.S. in fiscal year 2023, representing a market of more than $1.5B.

15:31 EDT Aimmune announces new clinical data on AR101 for Peanut Allergy - Aimmune Therapeutics reported additional results from its pivotal Phase 3 PALISADE trial of AR101 for the treatment of peanut allergy at the Congress of the European Academy of Allergy, Asthma, and Immunology 2018 in Munich. Aimmune previously announced that the trial met its primary and secondary efficacy endpoints in the pre-specified primary analysis of the 4-17 age cohort. Additional analyses including adults treated in the study were presented at EAACI. PALISADE enrolled a total of 554 patients ages 4-55. After approximately one year of treatment, clinical reactivity to peanut protein was assessed in an exit double-blind, placebo-controlled food challenge. The trial met its primary endpoint as 67% of AR101 patients ages 4-17 tolerated at least a 600-mg dose of peanut protein in the exit DBPCFC, compared to 4% of placebo patients. The lower-bound of the 95% confidence interval of the difference between treatment arms at the primary endpoint was 53%, greatly exceeding the pre-specified threshold of 15%. Based on these results, Aimmune plans to submit a Biologics License Application for AR101 to the U.S. Food and Drug Administration by the end of 2018, followed by a Marketing Authorisation Application to the European Medicines Agency in the first half of 2019. In the U.S., AR101 has FDA Fast Track Designation, as well as FDA Breakthrough Therapy Designation for peanut-allergic patients ages 4-17.

15:23 EDT Alcoa provides update to partial restart of smelter at Warrick Operations - Alcoa announced that as a result of a temporary power outage at the Warrick Operations smelter near Evansville, Indiana, it has shut down one of the three potlines that are part of the Warrick aluminum smelter restart. The decision was made with a focus on safety and to protect the assets. Alcoa is assessing the effects of this event, including the timing of the overall restart, and will provide an update as more information is available. The annual capacity of the affected potline is approximately 50,000 metric tons.

11:19 EDT Jumei announces disposal of equity interest portion in BabyTree - Jumei announced that it has entered into a definitive agreement to sell a certain number of ordinary shares of BabyTree Group, representing 4.0% of the total issued and outstanding share capital of BabyTree Group immediately after the sale, to a third-party investor for an aggregate consideration of approximately $86.5M. Immediately after the sale, Jumei will hold approximately 3.33% of the total issued and outstanding share capital of BabyTree Group.

11:15 EDT Silvercorp Metals declares increased dividend - Silvercorp Metals announced that its Board of Directors declared a semi-annual dividend of $0.0125 per share to be paid to all shareholders of record at the close of business on June 8, 2018, with a payment date of the dividend scheduled on or before June 29, 2018. The dividends are considered eligible dividends for Canadian tax purposes.

11:11 EDT airBaltic orders up to 60 Bombardier CS300 aircraft - Bombardier Commercial Aircraft and Air Baltic Corporation AS announced that the parties have executed a firm purchase agreement for the sale and purchase of 30 CS300 aircraft with options and purchase rights for an additional 30 aircraft of the same type. Based on the list price of the CS300 aircraft, the firm order is valued at approximately $2.9B. This amount would increase to nearly $5.9B should all 15 options and 15 purchase rights be exercised. Deliveries pertaining to this new order are scheduled to commence in the fourth quarter of 2019. Prior to this order, airBaltic had ordered 20 CS300 aircraft. The airline is currently operating revenue service with eight CS300 aircraft.

11:06 EDT Embraer selects Viasat as connectivity provider on Legacy 450/500 executive jets - Viasat (VSAT) announced Embraer (ERJ) has selected the company's high-speed, high-capacity Ka-band connectivity solution for its Legacy 450 and Legacy 500 executive jets. The Viasat system is prepared to serve the business jet users' connectivity demands of today, while keeping pace with future bandwidth demands. Viasat will be the Ka-band broadband satellite connectivity provider on the Legacy 450 and Legacy 500 airframes. Aircraft will be equipped with Viasat's Global Aero Terminal 5510, which will tap into the ViaSat-1, ViaSat-2 and European Ka-band satellite platforms, and will be forward-compatible with Viasat's future-generation satellite constellation, ViaSat-3-enabling use of the ViaSat-3 capacity with no additional hardware upgrades. ViaSat-3 is an ultra-high capacity satellite platform, which will be comprised of three ViaSat-3 class satellites offering global coverage. Each ViaSat-3 satellite is expected to deliver one terabit per second capacity.

10:58 EDT Amazon announces first fulfillment center in Oklahoma - Amazon announced plans to open its first fulfillment center in Oklahoma, creating more than 1,500 full-time jobs by the end of 2019. The more than 600,000-square-foot, state-of-the-art facility will be located in Oklahoma City.